ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,018.39
-0.34%
Dow Jones
37,903.29
0.23%
US Dollar vs MXN
16.9587
0.09%
Brent Oil
83.495
-0.05%
Bitcoin
57,027.64
-2.08%
Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Lyell Immunopharma Inc (LYEL)

  7. Lyell Immunopharma Inc (LYEL) Noticias

LYEL

Lyell Immunopharma (LYEL)

Lyell Immunopharma Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:LYEL
FechaHoraFuenteTítuloSímboloCompañía
05/03/202415:30GlobeNewswire Inc.Lyell Immunopharma Announces the Acceptance of Three Abstracts for Presentation at 2024 AACR Annual MeetingNASDAQ:LYELLyell Immunopharma Inc
28/02/202415:07Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LYELLyell Immunopharma Inc
28/02/202415:05GlobeNewswire Inc.Lyell Immunopharma Reports Business Highlights and Financial Results for the Fourth Quarter and Full Year 2023NASDAQ:LYELLyell Immunopharma Inc
26/02/202415:05GlobeNewswire Inc.Lyell Immunopharma Announces Participation in March Investor ConferencesNASDAQ:LYELLyell Immunopharma Inc
13/02/202419:24Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LYELLyell Immunopharma Inc
03/01/202415:05GlobeNewswire Inc.Lyell Immunopharma to Participate in 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:LYELLyell Immunopharma Inc
09/11/202315:05GlobeNewswire Inc.Lyell Immunopharma Receives FDA Orphan Drug Designation for LYL845 for the Treatment of MelanomaNASDAQ:LYELLyell Immunopharma Inc
07/11/202315:14Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:LYELLyell Immunopharma Inc
07/11/202315:05GlobeNewswire Inc.Lyell Immunopharma Reports Business Highlights and Financial Results for the Third Quarter 2023NASDAQ:LYELLyell Immunopharma Inc
31/10/202308:00GlobeNewswire Inc.Lyell Immunopharma Presentations at SITC Highlight New Nonclinical Data on Product Candidates and Innovative Technology to Shorten TIL ManufacturingNASDAQ:LYELLyell Immunopharma Inc
27/09/202308:00GlobeNewswire Inc.Lyell Immunopharma Announces the Acceptance of Six Abstracts for Presentation at 2023 Society for Immunotherapy of Cancer (SITC) Annual MeetingNASDAQ:LYELLyell Immunopharma Inc
11/09/202307:00PR Newswire (US)Cellares and Lyell to Evaluate Automated Manufacturing of Lyell's CAR T-Cell Therapy on Cellares' Cell Shuttle PlatformNASDAQ:LYELLyell Immunopharma Inc
11/09/202307:00GlobeNewswire Inc.Cellares and Lyell to Evaluate Automated Manufacturing of Lyell’s CAR T-Cell Therapy on Cellares’ Cell Shuttle PlatformNASDAQ:LYELLyell Immunopharma Inc
31/08/202315:05GlobeNewswire Inc.Lyell Immunopharma to Participate in Upcoming Investor ConferencesNASDAQ:LYELLyell Immunopharma Inc
08/08/202315:05GlobeNewswire Inc.Lyell Immunopharma Reports Business Highlights and Financial Results for the Second Quarter 2023NASDAQ:LYELLyell Immunopharma Inc
05/07/202315:05GlobeNewswire Inc.Lyell Immunopharma Appoints Matthew Lang as Chief Business OfficerNASDAQ:LYELLyell Immunopharma Inc
21/06/202315:55Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:LYELLyell Immunopharma Inc
20/06/202315:52Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:LYELLyell Immunopharma Inc
07/06/202315:05GlobeNewswire Inc.Lyell Immunopharma to Participate in the Goldman Sachs Global Healthcare ConferenceNASDAQ:LYELLyell Immunopharma Inc
04/05/202315:05GlobeNewswire Inc.Lyell Immunopharma Reports Business Highlights and Financial Results for the First Quarter 2023NASDAQ:LYELLyell Immunopharma Inc
02/05/202315:05GlobeNewswire Inc.Lyell Immunopharma to Participate in BofA Securities Healthcare ConferenceNASDAQ:LYELLyell Immunopharma Inc
27/04/202315:13Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:LYELLyell Immunopharma Inc
28/02/202316:57Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:LYELLyell Immunopharma Inc
28/02/202315:05GlobeNewswire Inc.Lyell Immunopharma Reports Business Highlights and Financial Results for the Fourth Quarter and Full Year 2022NASDAQ:LYELLyell Immunopharma Inc
13/02/202316:04Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:LYELLyell Immunopharma Inc
09/02/202310:38Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:LYELLyell Immunopharma Inc
03/01/202315:05GlobeNewswire Inc.Lyell Immunopharma to Participate in 41st Annual J.P. Morgan Healthcare ConferenceNASDAQ:LYELLyell Immunopharma Inc
15/12/202206:00GlobeNewswire Inc.Lyell Immunopharma Appoints Lynn Seely, MD as President and Chief Executive OfficerNASDAQ:LYELLyell Immunopharma Inc
01/12/202215:05GlobeNewswire Inc.Lyell Immunopharma to Participate in BofA Securities Biotech ConferenceNASDAQ:LYELLyell Immunopharma Inc
10/11/202215:05GlobeNewswire Inc.Lyell Immunopharma to Participate in Barclays Virtual Fireside Chat SeriesNASDAQ:LYELLyell Immunopharma Inc
 Showing the most relevant articles for your search:NASDAQ:LYEL

Su Consulta Reciente

NASDAQ
GOOGL
Alphabet
COIN
ETHUSD
Ethereum
USOTC
BASFY
BASF (QX)
NASDAQ
QQQ
Invesco QQQ Trust Series 1
USOTC
RHHBY
Roche (QX)
CCOM
OILBRENT
Brent Oil
FX
EURMXN
Euro vs MXN
AMEX
XLV
Health Care Select Sector
AMEX
XLE
Energy Select Sector SPDR
NYSE
CVX
Chevron
USI
USTECH100
US Tech 100
USOTC
ADDYY
Adidas (QX)
NYSE
DIS
Walt Disney
USOTC
DTEGY
Deutsche Telekom (QX)
FX
USDMXN
US Dollar vs MXN
SPI
SP500
S&P 500
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados